Market Analysis and Insights: Global CRO in Clinical Trials Market
A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.
Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.
In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
The global CRO in Clinical Trials market size is projected to reach US$ 81290 million by 2028, from US$ 42980 million in 2021, at a CAGR of 9.5% during 2022-2028.
Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%.
In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical,with a share about 55%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRO in Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRO in Clinical Trials market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRO in Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRO in Clinical Trials market.
Global CRO in Clinical Trials Scope and Market Size
CRO in Clinical Trials market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global CRO in Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
Segment by Application
Pharmaceutical
Bio-pharm
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.
Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.
In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
The global CRO in Clinical Trials market size is projected to reach US$ 81290 million by 2028, from US$ 42980 million in 2021, at a CAGR of 9.5% during 2022-2028.
Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%.
In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical,with a share about 55%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRO in Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRO in Clinical Trials market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRO in Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRO in Clinical Trials market.
Global CRO in Clinical Trials Scope and Market Size
CRO in Clinical Trials market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global CRO in Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
Segment by Application
Pharmaceutical
Bio-pharm
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.